Adenomyomatosis of the gallbladder (AG) is a condition in which the inner wall of the gallbladder becomes thickened and nodular. It is a very common condition, affecting up to 10% of people in some populations. AG is often asymptomatic and is usually discovered incidentally during imaging for other issues. However, it can cause symptoms such as abdominal pain, nausea, and vomiting. In some cases, AG can lead to complications such as gallbladder cancer and cholecystitis. As such, it is important for doctors to be aware of the condition and to understand how it can be diagnosed and managed. This article will provide an overview of AG, including its causes, diagnosis, and treatment.
Adenomyomatosis of the gallbladder is a condition in which the inner wall of the gallbladder becomes thickened and nodular. It is caused by a buildup of mucus, bile, and other substances in the gallbladder. This buildup leads to the formation of small nodules, which can range in size from a few millimeters to several centimeters. AG can affect one or both sides of the gallbladder, and it can also affect different parts of the organ.
The exact cause of AG is not known. However, there are several risk factors that can increase a person’s likelihood of developing the condition. These risk factors include obesity, diabetes, and a high-fat diet. In addition, certain medications, such as steroids, can also increase the risk of developing AG.
AG is usually diagnosed during imaging tests, such as an ultrasound or CT scan. During these tests, the doctor will be able to see the thickened and nodular walls of the gallbladder. In some cases, a biopsy may also be performed to confirm the diagnosis.
In most cases, AG does not require treatment. However, if the condition is causing symptoms, it may be necessary to treat the underlying cause. For example, if the patient is overweight, they may be advised to lose weight. If the patient is taking steroids, they may be advised to stop taking them. In some cases, surgery may be necessary. This is usually only recommended if the patient is experiencing severe symptoms or if there is a risk of complications. Surgery may involve removing the gallbladder, or it may involve removing the nodules.
Adenomyomatosis of the gallbladder is a common condition that can cause symptoms such as abdominal pain, nausea, and vomiting. It is usually asymptomatic and is usually discovered incidentally during imaging tests. In most cases, AG does not require treatment, but if the patient is experiencing severe symptoms or if there is a risk of complications, surgery may be necessary. It is important for doctors to be aware of the condition and to understand how it can be diagnosed and managed.
1.
Psychedelic Therapy Tied to Reduced Depression, Anxiety.
2.
New drug resistance mechanism in melanoma leptomeningeal disease revealed by study.
3.
Research finds stark disparities in treatment and survival time for people with pancreatic cancer
4.
Tumor characteristics found to differ for melanomas in children, teens and young adults
5.
Relationship-building key to addressing oncologist shortages in rural care
1.
Artificial Intelligence in Oncology: Current Trends, Challenges and Future Outlook
2.
Colon cancer: Risk factors, warning signs and treatment options
3.
Exploring the Latest Advances in Hodgkin's Lymphoma Treatment
4.
Can We Repurpose BV-CHP for Better Outcomes in Peripheral T-Cell Lymphoma?
5.
The Expanding Horizon of PSMA: A Comparative Clinical Review of Theranostics in Prostate Cancer and Beyond
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC
2.
Efficient Management of First line ALK-rearranged NSCLC - Part VIII
3.
Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
5.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation